Singapore markets close in 3 hours 30 minutes
  • Straits Times Index

    +2.08 (+0.06%)
  • Nikkei

    -1,033.32 (-2.45%)
  • Hang Seng

    -245.56 (-1.34%)
  • FTSE 100

    +29.57 (+0.36%)
  • Bitcoin USD

    +2,582.25 (+4.29%)
  • CMC Crypto 200

    +105.17 (+8.78%)
  • S&P 500

    +30.81 (+0.55%)
  • Dow

    +247.10 (+0.62%)
  • Nasdaq

    +115.04 (+0.63%)
  • Gold

    -3.10 (-0.13%)
  • Crude Oil

    +0.23 (+0.28%)
  • 10-Yr Bond

    -0.0040 (-0.10%)
  • FTSE Bursa Malaysia

    +7.04 (+0.43%)
  • Jakarta Composite Index

    -42.48 (-0.58%)
  • PSE Index

    +75.57 (+1.14%)

Univest Securities, LLC Announces Closing of $5 Million Underwritten Public Offering for its Client Akanda Corp. (NASDAQ: AKAN)

Univest Securities, LLC
Univest Securities, LLC

New York, March 27, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of underwritten public offering (the “Offering”) of 3,087,443 common stock priced at $0.1217 per share, with pre-funded warrants exercisable for 37,997,190 shares with respect to the underwritten public offering for its client Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company.

Under the terms of the securities purchase agreement, the Company has agreed to sell to the institutional investors a total of 3,087,443 shares priced at $0.1217 per share, with pre-funded warrants exercisable for 37,997,190 shares. The purchase price of each pre-funded warrant is equal to the price per share, minus $0.0001, and the remaining exercise price of each pre-funded warrant will equal $0.0001 per share. The pre-funded warrants will be immediately exercisable and may be exercised at any time until all of the pre-funded warrants are exercised in full.

The aggregate gross proceeds to the Company was approximately $5 million.


Univest Securities, LLC acted as the sole underwriter.

The underwritten pubic offering was made pursuant to a shelf registration statement on Form F-1, as amended (File No. 333-277182), previously filed with and declared effective by the U.S. Securities and Exchange Commission (“SEC”) on March 19, 2024. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering were filed with the SEC and are available on the SEC's website located at Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, by contacting Univest Securities, LLC at, or by calling +1 (212) 343-8888.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Copies of the prospectus supplement relating to the underwritten pubic offering, together with the accompanying base prospectus, can be obtained at the SEC's website at

About Univest Securities, LLC

Registered with FINRA since 1994, Univest Securities, LLC provides a wide variety of financial services to its institutional and retail clients globally including brokerage and execution services, sales and trading, market making, investment banking and advisory, wealth management. It strives to provide clients with value-add service and focuses on building long-term relationship with its clients. For more information, please visit:

About Akanda Corp.

Akanda is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. Akanda’s portfolio includes Holigen, a Portugal-based cultivator, manufacturer and distributor with a prized EU GMP certified indoor grow facility; CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. The Company’s seed-to-patient supply chain also includes partnerships with California-based Cookies, the most globally recognized cannabis company in the world; Cansativa Group, a leading importer and distributor of medical cannabis in Europe; and Cellen Life Sciences’ Leva Clinic, one of the first fully digital pain clinics in the UK. For more information, please visit the Company's website:

Forward-Looking Statements

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may, “will, “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and the completion of the initial public offering on the anticipated terms or at all, and other factors discussed in the “Risk Factors” section of the registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at Univest Securities LLC and the Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:

Univest Securities, LLC
Edric Guo
Chief Executive Officer
75 Rockefeller Plaza, Suite 18C
New York, NY 10019
Phone: (212) 343-8888